No Data
No Data
No Data
Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 28% But Growth Is Lacking
Guan Hao Biology: Summary of the 2024 Semi-Annual Report
Guan Hao Biology: 2024 Semi-Annual Report
guanhao biotech (300238.SZ): net income in the first half of the year was 20.148 million yuan, a year-on-year decrease of 34.46%.
Guanhao Biotech (300238.SZ) announced its semi-annual report, with revenue of 0.19 billion yuan, a decrease of 10.02% year-on-year, net income of 20.148 million yuan, a decrease of 34.46% year-on-year, non-GAAP net income of 18.92 million yuan, a decrease of 31.33% year-on-year, and basic earnings per share of 0.08 yuan.
Guanhao Biotech (300238.SZ): The current bioartificial liver project is in the preclinical research stage.
Guanhao Biotech (300238.SZ) stated on the investor platform on August 19 that the company's bio-artificial liver project is currently in pre-clinical research stage.
As of August 9th, 2024, the total number of shareholders of Guanhao Biotech (300238.SZ) was 33,226.
As of August 9, 2024, Guanhao Biotech (300238.SZ) stated on its investor interactive platform that the total number of shareholders of the company is 33,226.
No Data